FDA grants accelerated approval to the first drug for Duchenne muscular dystrophy
The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...
Zika virus: Current global status, threats and concerns
Zika virus discovered in Uganda in 1947 is currently making the world headlines for its outbreak in South America...
FDA issues strong warnings for opioid analgesics
Opioids like oxycodone, hydrocodone, morphine etc. are powerful pain-killers used primarily to manage chronic pain e.g. Opioid analgesics cough...
Liraglutide demonstrated CV benefits among Diabetes Drugs
Liraglutide (Victoza®) is an injectable glucagon-like peptide-1 (GLP-1) receptor antagonist indicated in addition to diet and exercise to improve...
Ertugliflozin Shows Promising Results as Therapy for Diabetes
The health and economic costs of diabetes are enormous. Considerable efforts are being made to develop new and more...